Cameron John Reynolds - Jan 24, 2024 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Signature
/s/ Cameron John Reynolds
Stock symbol
VNRX
Transactions as of
Jan 24, 2024
Transactions value $
$0
Form type
4
Date filed
1/26/2024, 04:01 PM
Previous filing
Dec 11, 2023
Next filing
Jun 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Award $0 +50.2K +2.94% $0.00 1.75M Jan 24, 2024 Direct F1
holding VNRX Common Stock 1.01M Jan 24, 2024 By Concord International, Inc. F2
holding VNRX Common Stock 34.1K Jan 24, 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 28, 2023, the reporting person was awarded 118,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 50,150 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 16,717 units, 16,717 units, and 16,716 units on each of September 28, 2024, September 28, 2025 and September 28, 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.
F2 The shares of common stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.